Viewing Study NCT04455503


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-05-22 @ 10:49 PM
Study NCT ID: NCT04455503
Status: TERMINATED
Last Update Posted: 2024-02-21
First Post: 2020-06-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1
Sponsor: Evaxion Biotech A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma Stage IV View
None Melanoma Stage III View
Keywords: